Erchonia, which specialises in providing low level laser treatment for health care applications has announced that a new double-blind, 40-subject, randomised and sham controlled study has established that the company’s non-invasive Zerona laser is very effective in reducing the circumference of the upper arm.
Traditionally reducing the circumference of the upper arm through diet, surgery and exercise has been very difficult. Zerona laser uses low light laser to remove fat from cells without destroying them.
The subjects that were tested were of the age groups of 18 to 65 and who had the willingness to consistently maintain their diet and exercise regime. These patients also did not have any critical or chronic illness or any other surgical problems. All of the 40 subjects were treated with the Zerona 635 nm low-level laser device or the sham laser device for a total of six times with each treatment lasting for 20 minutes. After the treatment was completed, it was established that in the group that was treated with Zerona laser the bilateral circumference was reduced by 4 cm whereas the group that was treated with the sham laser device showed no change. The active treatment group had a success rate of 60% and the combined reduction of the upper arm circumference was 1.25% more than the sham laser treatment group. Both groups however did not show any change in their body mass index. Patients who were treated with Zerona had no pain or discomfort and expressed a higher level of satisfaction than the sham treatment group.
The results of the study have been presented at the 5-CC Conference held in France and the company is in the process of presenting these results for peer-review publication. Zerona has already been approved by the FDA.